U.S. Software Stock News

Recent performance snapshot for Bank OZK Bank OZK (OZK) has attracted fresh attention after recent share price moves, with the stock showing modest changes over the past week, month and past 3 months, as well as a more extended record over 1 and 5 years. See our latest analysis for Bank OZK. The recent 90-day share price return of 5.53% and year to date share price return of 3.10% suggest momentum has been building gradually, while the 1-year total shareholder return of 1.34% shows a more...

United Parks & Resorts recently announced that SeaWorld returned in early 2026 with an expanded coast-to-coast live music series, offering full-length concerts by artists such as Flo Rida, Boyz II Men, and The Beach Boys in Orlando, San Diego, and San Antonio at no extra cost beyond park admission. This move places live entertainment at the center of the guest experience and is designed to deepen Annual Pass value by giving members flexible, season-long access to multiple concerts across...

In Q4 2025, Select Medical Holdings Corporation disclosed spending US$630,000 on lobbying related to regulations for long-term acute care hospitals, inpatient rehabilitation facilities, and outpatient rehabilitation clinics, with a particular focus on Medicare payment issues, while institutional investors showed mixed positioning and analysts recently issued positive ratings. This combination of targeted policy engagement and favorable analyst sentiment highlights how regulatory influence...

WEX (WEX) is in focus after Health-E Commerce agreed to integrate its FSA Store and HSA Store directly into the WEX benefits portal, aiming to simplify how FSA and HSA users shop and pay for eligible healthcare expenses. See our latest analysis for WEX. For context, WEX shares trade at US$157.69, with a 30 day share price return of 5.11% and a year to date share price return of 6.27%. The 1 year total shareholder return of 14.20% and 5 year total shareholder return of 21.84% point to weaker...

ICL Group was recently upgraded by Zacks to a Rank #2 (Buy) after analysts raised their earnings estimates, with the consensus forecast climbing 11.1% over the past three months, signaling a more favorable earnings outlook than previously expected. This upward revision in earnings expectations suggests analysts see improving profit potential for ICL’s specialty minerals and chemicals portfolio, which could influence how investors view the company’s longer-term business prospects and risk...

If you are wondering whether Darling Ingredients is reasonably priced or offering a margin of safety right now, this article will walk through what the current share price might be implying about its value. The stock recently closed at US$39.57, with returns of 1.3% over 7 days, 14.4% over 30 days, 5.1% year to date, 8.0% over 1 year, and a 39.7% and 40.7% decline over 3 and 5 years respectively. Taken together, these figures give mixed signals about how the market has been treating the...

If you are wondering whether AtaiBeckley is still reasonably priced after its recent run, this article will help you size up what you are paying for each dollar of potential future value. The stock recently closed at US$3.64, with returns of 149.3% over the last year and 91.6% over three years, alongside a 2.9% decline over the past week and a 10.3% decline over the last month, so recent trading has been choppy even as longer term returns remain strong. Recent news has focused on AtaiBeckley...

Recent share performance and business snapshot Spectrum Brands Holdings (SPB) has drawn attention after recent share price moves, including a 2.4% decline on the day and a 4.4% drop over the past week. This has prompted investors to reassess its profile. The company last closed at $61.93. Returns show a 1.1% gain over the past month and a 15.3% rise over the past 3 months, while the 1 year total return stands at a 25.3% decline. Over longer periods, Spectrum Brands Holdings shows a 3 year...

If you are wondering whether Herbalife’s recent share price levels still make sense, this article walks through what the current price could imply about the company’s value. Herbalife’s stock last closed at US$16.97, with returns of 13.3% over the past week, 18.7% over the past month, 32.4% year to date, and 158.3% over the past year, compared with a 2.3% annualised decline over three years and a 65.8% decline over five years. Investors have been reacting to a mix of company specific...

If you are wondering whether Marvell Technology is attractively priced or just feels cheap after a tough run, this article is designed to walk you through the key valuation angles in a clear, practical way. Marvell's share price closed at US$80.46, with returns of a 3.3% decline over 7 days, a 1.5% decline over 30 days, a 10.0% decline year to date, a 35.3% decline over 1 year, but a 106.1% gain over 3 years and a 56.0% gain over 5 years. This gives a mixed picture for anyone thinking about...

Inspire Medical Systems (INSP) is back in focus after issuing preliminary, unaudited 2025 revenue figures that point to double digit growth, updating its 2026 outlook, and appointing Matt Osberg as its new Chief Financial Officer. See our latest analysis for Inspire Medical Systems. Despite the fresh guidance and CFO appointment, momentum in Inspire Medical Systems' shares has cooled recently. The 1 month share price return shows a 22% decline and the 7 day share price return shows a 6.3%...

Scorpio Tankers (STNG) has been in focus after outlining a fleet renewal plan that includes selling several LR2 vessels, adding newbuildings across tanker classes, and signing fresh five year time charter agreements. See our latest analysis for Scorpio Tankers. Those fleet moves and the shift to a net cash position have arrived alongside a 13.99% 1 month share price return and an 18.90% year to date share price return. The 5 year total shareholder return is very large, and together these...

One Stop Systems (OSS) recently reported receiving an approximately US$1.2 million pre-production order from a new U.S. defense prime contractor to supply ruggedized compute and visualization systems for U.S. Army combat vehicles. See our latest analysis for One Stop Systems. That new U.S. Army contract comes as momentum in the shares has picked up, with a 57% 30 day share price return and a 106% 90 day share price return. The 1 year total shareholder return of 161% points to strong longer...

In recent days, Citi upgraded Zoom Communications, citing the company’s expanding multi-product platform and AI initiatives such as its Custom AI Companion and Contact Center offerings as key growth drivers. This highlights a growing divide between earlier concerns about Zoom’s modest billing trends and newer optimism around its ability to monetize AI-enabled collaboration tools. We’ll now examine how Citi’s renewed focus on Zoom’s AI-driven, multi-product strategy could influence the...

If you are wondering whether CRISPR Therapeutics' share price still makes sense after recent moves, this article focuses squarely on what the current valuation might be telling you. The stock last closed at US$53.51, with returns of a 0.6% decline over 7 days, a 2.2% decline over 30 days, a 0.5% decline year to date, a 32.0% gain over 1 year, 7.9% over 3 years, and a 71.6% decline over 5 years, which gives a mixed picture for investors thinking about entry or exit points. Recent news...

Alexandria Real Estate Equities, Inc. recently appointed John Hart Cole as Co-President & Co-Regional Market Director Seattle, while grappling with a 45% dividend cut, weaker third quarter 2025 results, and a real estate impairment tied largely to its Long Island City property. The combination of leadership changes, sector headwinds in life sciences real estate, and multiple securities class action filings over Long Island City disclosures is reshaping how investors assess Alexandria’s risk...

Why Exelixis (EXEL) Is On Investors’ Radar Today Exelixis (EXEL) has drawn attention after recent trading left the shares at a last close of US$43.96, prompting investors to reassess the oncology company’s profile and the value they place on its pipeline. See our latest analysis for Exelixis. Despite a 3.26% 1 day share price decline and a flat week, Exelixis has a 4.67% 30 day share price return and a 21.44% 1 year total shareholder return, while the 3 year total shareholder return of...

StubHub Holdings (STUB) is back in focus as multiple securities class action lawsuits over its 2025 IPO disclosures approach a January 23 lead plaintiff deadline, keeping legal and cash flow questions front and center for shareholders. See our latest analysis for StubHub Holdings. Recent trading reflects elevated uncertainty, with a 7 day share price return of 25.29% and a 30 day gain of 14.37% partly offsetting a 90 day share price return of negative 6.71%. The stock is at $16.0 with year to...

Event context and recent stock performance Indivior (INDV) has been on investors’ radar after recent share price swings, with the stock showing a 1 day return of 1.05% and a 7 day decline of 8.18%. Over the past month the share price return is a 9.49% decline, contrasting with a 32.92% gain over the past 3 months. This may prompt investors to reassess how current pricing lines up with Indivior’s fundamentals. See our latest analysis for Indivior. At a share price of US$32.54, Indivior’s...

Recently, KeyBanc downgraded Mach Natural Resources from Overweight to Sector Weight, citing integration challenges around new Central Basin Platform and San Juan Basin assets and concerns about investor interest, while the company also announced a board change with Francis A. Keating II resigning and Christopher J. Burn joining. This combination of an analyst downgrade focused on execution risk and a refreshed board has sharpened attention on how effectively Mach can integrate acquisitions...

Event context for Accelerant Holdings Accelerant Holdings (ARX) has drawn investor attention after recent share price moves, with the stock showing a negative 1 day return of 2.1% and a negative 7 day return of 4.8%. Over the past month the stock posted a negative return of 4.5%. Over the past 3 months it shows a 16.4% gain, setting up a contrast that raises questions about how investors are weighing its growing revenue and current net loss. See our latest analysis for Accelerant Holdings. At...

If you are wondering whether General Dynamics is still fairly priced after its strong run, this article walks through what the current market price might be implying about the company. The stock recently closed at US$367.38, with returns of 3.8% over 7 days, 9.2% over 30 days, 7.0% year to date, 40.4% over 1 year, 68.0% over 3 years, and 168.1% over 5 years. This performance has put valuation firmly on many investors' radar. Recent attention on defense and aerospace contractors, including...

In recent days, Roblox’s new viral game “Escape Tsunami For Brainrots” has rapidly become one of the platform’s top five experiences, drawing strong user engagement and helping underpin expectations for higher full-year 2025 revenue even as the company still anticipates a consolidated net loss. Analysts at firms including BMO Capital and Morgan Stanley have highlighted the title’s early success as a potential driver of bookings strength and as evidence of Roblox’s ability to convert...

If you are wondering whether Travelers Companies is offering fair value at its current price, you are not alone. This article is designed to walk you through that question step by step. The stock closed at US$269.42, with returns of a 4.4% decline over 7 days, a 7.5% decline over 30 days, a 5.5% decline year to date, 14.3% over 1 year, 53.9% over 3 years and 104.3% over 5 years. This naturally raises questions about what is already priced in. Recent news flow around Travelers Companies has...